Articles tagged with Pancreatitis
Acute pancreatitis is a sterile inflammation triggered by false alarm molecules, leading to the formation of harmful DNA-protein structures called NETs. Researchers found that neutrophils can activate these structures, causing pancreas damage.
Researchers have discovered a new signaling intermediate, leukotriene B4, which is synthesized and released by pancreatic acinar cells. This finding provides a potential target for the development of novel therapies for pancreatitis, a common disorder that complicates many ailments.
A 12-year study found that genetic variants, combined with lifestyle factors like smoking and drinking, can lead to chronic pancreatitis. Researchers identified a specific gene variant that may fail to protect pancreatic cells from injury, increasing the risk of inflammation and scarring.
A study published in Nature Genetics has identified a genetic marker that increases the risk of pancreatitis in patients prescribed thiopurine drugs. Researchers found that 17% of patients with two copies of the marker are at high risk, four times more than those with one copy.
Acute pancreatitis is a severe condition where the pancreas digests itself, leading to abdominal pain, vomiting, and systemic inflammation. Recent research suggests that insulin may prevent toxic effects of alcohol and fatty acid metabolites on pancreatic acinar cells.
Researchers found nine variants in the CFTR gene associated with pancreatitis, sinusitis, and male infertility, but leave the lungs unaffected. The study identifies mechanisms behind these conditions, paving the way for treatments and potential medications.
A retrospective cohort study found patients taking JANUVIA and metformin initiated insulin therapy at a slower rate than those taking a sulfonylurea and metformin. The study suggests that real-world data may provide insight into the effects of different oral treatment regimens on the initiation of insulin use.
Researchers found a higher risk of pancreatic cancer in patients with acute pancreatitis, particularly those over 40. The study suggests that patients with acute pancreatitis should be evaluated for pancreatic cancer using esophageal ultrasound.
A new study found that postmenopausal hormone replacement therapy (HRT) may increase the risk of acute pancreatitis. The risk was higher among women who used systemic therapy and those who had used HRT for more than 10 years.
Researchers at Cardiff University have made a breakthrough in treating acute pancreatitis by reducing calcium flow into pancreatic cells, stopping the root cause of the disease. The study shows promise for developing an effective treatment for this often fatal disease.
A post-hoc analysis found that patients with Type 2 diabetes and mild renal impairment treated with JANUVIA achieved similar blood sugar reductions as those treated with sulfonylureas, with significantly fewer hypoglycemia events. Patients taking JANUVIA also experienced weight loss, whereas those on sulfonylureas gained weight.
The AGA's 13th annual special issue focuses on the pancreas, presenting a variety of topics related to exocrine function, endocrine regulation, and clinical manifestations. Key findings highlight the importance of innovative treatments for patients with pancreatic diseases.
A new class of diabetes drugs has been linked to a doubling of the risk of pancreatitis in people taking them. Researchers found that patients who took glucagon-like peptide-1-based therapies were twice as likely to be hospitalized with acute pancreatitis as those on other medications.
A new study from Karolinska Institutet reveals that cortisone increases the risk of acute pancreatitis. Patients treated with cortisone are recommended to avoid alcohol and smoking to minimize the risk. The study found a 70% higher risk of developing acute pancreatitis among those taking cortisone tablet form.
A team from the University of Pennsylvania School of Medicine has identified a molecular master switch for pancreatic cancer, which could serve as a potential predictor of treatment outcome. The researchers found that Prrx1 and Sox9 regulate the emergence of an intermediate cell type that can give rise to cancer.
Researchers identified a genetic variant on chromosome X that predicts high-risk men who drink heavily are at risk for developing chronic pancreatitis. The discovery enables doctors to identify patients with early signs of pancreatitis or acute attacks, allowing them to take preventative action and give the pancreas a chance to heal.
A new study published in Gastroenterology suggests that the immune system protein NFATc3 plays a significant role in the development of acute pancreatitis. The researchers found links between NFAT and trypsinogen activation, neutrophil recruitment, and tissue damage in mice.
A meta-analysis of 16 statin trials and 7 fibrate trials found that statin therapy was associated with a 21% lower risk of pancreatitis. In contrast, fibrates showed no significant risk reduction. Lifestyle modifications remain important for improving lipid profiles in patients with hypertriglyceridemia.
A diet high in vegetables may help prevent acute pancreatitis by reducing oxidative stress. The study found that individuals who consumed the most vegetables daily were 44% less likely to develop the condition than those who ate the least. This protective effect was strongest among heavy drinkers and overweight individuals.
Researchers found that high levels of interleukin-6 (IL-6) prolong inflammation in obese mice with acute pancreatitis. IL-6 is also linked to the severity of the disease in obese subjects.
A study led by University of Michigan physicians shows a single dose of indomethacin can prevent post-ERCP pancreatitis, reducing hospitalizations and costs. The medication is part of a category of non-steroid anti-inflammatory drugs that inhibits an inflammatory response in the pancreas.
A new endoscopic procedure, transgastric necrosectomy, has been shown to reduce major complications and death in patients with infected severe pancreatitis compared to traditional surgical methods. The study found that the procedure resulted in lower proinflammatory response and reduced rates of multiple organ failure.
Researchers at Cardiff University have secured a £2M MRC Programme Grant to investigate the potential of a calcium-like molecule in protecting against enzymes that trigger pancreatitis. The team aims to better understand stellate cells, which may be the link between chronic pancreatitis and pancreatic cancer.
Researchers found that high levels of dendritic cells in the pancreas can alleviate cellular stress caused by severe inflammation, while low levels are associated with exacerbated pancreas injury. Dendritic cells play a critical protective role in pancreatic organ survival.
Researchers find that toxic byproducts from unsaturated fat breakdown lead to severe inflammation, cell death, and multi-system organ failure in obese acute pancreatitis patients. The study provides new insight into how fat can induce complications after sudden inflammatory illnesses.
A study published in the British Journal of Surgery found that drinking just one measure of spirits can increase the risk of acute pancreatitis. The research followed 84,601 people and found that high single occasion spirits consumption was associated with higher levels of diabetes.
A new low-cost test for acute pancreatitis has been developed by University of Texas at Austin scientists, offering faster results than existing tests. The sensor, built with simple materials like gelatin, milk protein, and aluminum foil, can diagnose the disease in under an hour.
A Cardiff University-led study has discovered a protein, calmodulin, that protects pancreatic cells against the harmful effects of alcohol. The findings could lead to the development of new treatments for pancreatitis and reduce the risk of pancreatic cancer.
A new study published in Clinical Gastroenterology and Hepatology found that chronic pancreatitis cases are not exclusively caused by alcohol consumption, with over 50% of patients having no identifiable cause. Genetic factors and environmental interactions may play a role in disease development.
A study found that combined treatments for severe acute pancreatitis are safe and effective in managing the disease, resulting in shorter hospitalizations and fewer radiological procedures. Primary conservative treatment also showed promise in avoiding surgery and improving patient outcomes.
Researchers found that both nasogastric and nasointestinal feeding approaches were feasible, safe, and effective in most patients with severe acute pancreatitis. This study suggests that nasogastric feeding may be a viable option for enteral nutrition in these patients.
A study found that circulating lymphocyte depletion is a characteristic of human severe and necrotizing acute pancreatitis. Serum interleukin-6 and macrophage migration inhibitory factor concentrations are also key predictors of disease severity and complications.
Researchers at LA BioMed found that patients with mild gallstone pancreatitis can safely undergo surgery within 48 hours of admission, reducing hospital stay lengths by a day. This new approach aims to shorten hospital stays and improve outcomes for these patients.
A study published in GIE: Gastrointestinal Endoscopy examined polyp detection rates at screening colonoscopy and identified factors contributing to variability. Procedure time was found to be significantly associated with polyp detection rates across all models, indicating the need for quality standards for colonoscopy performance.
A new study reveals that only heavy alcohol consumption above 5 drinks per day significantly raises the risk of chronic pancreatitis. Dose-dependent smoking also contributes to the risk, with smokers having more severe pancreatitis and longer smoking history.
A new study suggests that the widely used diabetes medication Januvia may cause pancreatitis and increase the risk of pancreatic cancer in some patients. Researchers found that combining Januvia with the older diabetes drug metformin helped mitigate these effects, suggesting a potential way to safely use GLP-1 class drugs.
Researchers developed a method to estimate fetal radiation doses from ERCP procedures, revealing that doses may occasionally exceed 10 mGy. The study emphasizes the need for physicians to accurately estimate fetal radiation exposure to determine appropriate treatment and minimize risks.
A recent study found that smoking is associated with an increased risk of acute and chronic pancreatitis. The risk of developing the disease was higher in smokers than non-smokers, regardless of alcohol consumption or gallstone disease.
A study suggests that measuring intra-abdominal pressure can help predict abdominal compartment syndrome in acute pancreatitis patients. The research team recommends IAP monitoring for patients with severe acute pancreatitis (SAP) to prevent mortality.
This study investigates the efficacy of continuous regional arterial infusion (CRAI) using gabexate mesilate in treating severe acute pancreatitis. CRAI significantly reduced mortality rate and incidence of infectious complications compared to conventional systemic therapy.
Researchers found serum TGF-beta1 and s-fractalkine levels significantly increased in patients with chronic pancreatitis compared to controls. Measurement of these markers may help diagnose early-stage CP and evaluate the severity status of the disease.
A study found that hypertriglyceridemia is independently associated with the severity of acute pancreatitis and leads to systemic complications. High triglyceride levels were linked to increased incidence of admission hypocalcemia, renal failure, shock, infection, and mortality in patients with severe acute pancreatitis.
This study investigates whether delayed ethyl pyruvate therapy can attenuate experimental SAP via reducing serum HMGB1 levels in rats. The results showed that ethyl pyruvate significantly reduced serum HMGB1 levels, protected against liver, renal, and lung injury, and prolonged survival time in rats.
Researchers found that autophagy promotes premature activation of trypsinogen, a digestive enzyme that can damage pancreatic cells. In rodents with pancreatitis, high levels of autophagy were observed, and blocking the process reduced symptoms. The study reveals autophagy as a potential trigger for pancreatitis in mice.
Patients with severe acute pancreatitis who received probiotics had higher mortality rates than those receiving a placebo. The study suggests that probiotics may not be effective in preventing infectious complications and modulating the immune system in these patients.
A study published in the Journal of the American College of Surgeons found that early cholecystectomy significantly reduces hospital stays in patients with mild to moderate gallstone pancreatitis. The procedure can benefit both individual patients and hospitals by reducing hospital time by three or four days.
Researchers found no link between the reg1 gene and pancreatic stone formation in patients with tropical calcific pancreatitis. The study suggests alternative mechanisms, such as calcium signaling, may be involved in stone formation.
A large dose of dexamethasone has been found to improve survival rates and reduce inflammation in rats with severe acute pancreatitis. The treatment also alleviated pancreatic tissue damage and induced apoptosis in acinar cells.
A study of 124 patients with acute viral hepatitis found that 5.65% had mild pancreatitis, all of whom recovered on conservative management. Patients with severe abdominal pain should undergo serum amylase and ultrasonography to rule out pancreatitis as a cause.
A case report describes an 86-year-old woman who developed acute pancreatitis and cholangitis after her gastrostomy tube migrated into the duodenum. The malpositioned tube caused duodenal obstruction, leading to severe symptoms that improved upon repositioning the tube.
A systematic review found that early nasogastric enteral nutrition is effective and safe for treating severe acute pancreatitis. It appears to be a cost-effective alternative to conventional nutritional routes, with no worsening of clinical outcomes.
A study by Arlette Darfeuille-Michaud and colleagues reveals that CEACAM6 expression promotes adherent-invasive E. coli's colonization in intestinal epithelial cells of patients with Crohn's disease, indicating a potential diagnostic marker for the condition. Meanwhile, another study by Andrea Hevener and colleagues shows that macropha...
Research reveals that statins increase the risk of acute pancreatitis by 40%, but the occurrence is still relatively rare. The study found that patients on low and high doses developed pancreatitis, suggesting that starting at a low dose may not prevent the side effect.
Researchers at the University of Liverpool discovered that caffeine in coffee can partially close special channels within cells, reducing damaging effects of alcohol on the pancreas. This finding suggests a potential new target for chemical agents to treat pancreatitis and warns against binge drinking.
The study reveals that VAMP8 is essential for the normal functioning of pancreatic acinar cells, which produce digestive enzymes. Mice lacking VAMP8 showed reduced levels of digestive enzymes and partial resistance to pancreatitis, suggesting a potential link between VAMP8 and this condition.
Researchers found that genetic mutations in people with chronic pancreas inflammation are associated with an increased risk of pancreatitis. The study identified specific mutations in the CF and PSTI genes, which can lead to a 900-fold increase in pancreatitis risk for those with two mutations.
A new minimally invasive procedure called endoscopic pancreatic sphincterotomy (EPS) has shown promise in providing long-term pain relief for patients with chronic pancreatitis. According to a recent study by Johns Hopkins physicians, 62% of patients reported significant improvement in their pain levels after undergoing the procedure.
Researchers found a strong association between the cystic fibrosis gene and chronic pancreatitis, revealing genetics plays a significant role in its development. The study's findings have significant implications for treating patients with this condition, including those who are not heavy drinkers.